The landscape of modern nicotine consumption has shifted dramatically over the past two decades, with electronic cigarettes frequently marketed as…
Read More
A common vape flavoring may disrupt early embryo development
A groundbreaking study led by researchers at the University of California, Riverside (UCR) has identified a significant biological mechanism linking…
Read More
A common vape flavoring may disrupt early embryo development
The landscape of modern nicotine consumption has shifted dramatically over the past two decades, with electronic cigarettes frequently marketed as…
Read More
A common vape flavoring may disrupt early embryo development
The landscape of public health has long grappled with the rapid evolution of nicotine delivery systems, but a groundbreaking study…
Read More
A common vape flavoring may disrupt early embryo development
The landscape of public health has long grappled with the rapid evolution of nicotine delivery systems, most notably electronic cigarettes,…
Read More
A common vape flavoring may disrupt early embryo development
The landscape of public health has long grappled with the rapid evolution of consumer nicotine products, particularly the meteoric rise…
Read More
Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
